Soluble PD-L1 and B7-H4 serum levels during the course of physiological pregnancy

Am J Reprod Immunol. 2022 Mar;87(3):e13519. doi: 10.1111/aji.13519. Epub 2022 Jan 12.

Abstract

Problem: The aim of this study was to evaluate the soluble programmed death-ligand (sPD-L1) and soluble B7-H4 (sB7-H4) serum concentration levels longitudinal throughout the three trimesters of uncomplicated pregnancies. METHOD OF THE STUDY: sPD-L1 and sB7-H4 levels were determined with enzyme-linked immunosorbent assay (ELISA). The patients (n = 26) were divided into three groups according to the pregnancy trimester. Among 26 women involved in the study 14 had longitudinal sB7-H4 and sPD-L1 measurements in each trimester of pregnancy.

Results: During the course of pregnancy, the sB7-H4 blood serum levels were significant higher in second trimester than in first and third trimester, whereas sPD-L1 levels increased significantly over the course of pregnancy.

Conclusion: The highest serum levels of sPD-L1 in the third trimester suggest increasing suppression of maternal immunity throughout pregnancy, whereas elevated sB7-H4 concentration levels in second trimester suggests different profile of T-cell regulation in physiological pregnancy.

Keywords: B7-H4; PD-L1; pregnancy.

MeSH terms

  • B7-H1 Antigen*
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Pregnancy
  • Serum*
  • T-Lymphocytes
  • V-Set Domain-Containing T-Cell Activation Inhibitor 1

Substances

  • B7-H1 Antigen
  • V-Set Domain-Containing T-Cell Activation Inhibitor 1